Back to Journals » International Journal of Nanomedicine » Volume 14

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

Total article views   HTML views PDF downloads Totals
6,848 Dovepress* 6,348+ 1,182 7,530
PubMed Central* 500 105 605
Totals 6,848 1,287 8,135
*Since 6 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar